US 6838076
Pulmonary administration of chemically modified insulin
expired A61KA61K38/28A61K47/60
Quick answer
US patent 6838076 (Pulmonary administration of chemically modified insulin) held by Nektar Therapeutics expires Mon Dec 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Jan 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 44
- CPC classes
- A61K, A61K38/28, A61K47/60, A61P, A61P3/08